Evidence map›Paper›PMID 30606178›Full record

ArticleBMC complementary and alternative medicine2019

The anti-obesity effects of Tongbi-san in a high-fat diet-induced obese mouse model.

Yea-Jin Park, Gui-Sun Lee, Se-Yun Cheon, Yun-Yeop Cha, Hyo-Jin An

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Impact ofAdvanced pharmaceutical bulletin · 2025
    Article
  3. Article
  4. Article
  5. Heliyon · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Chemical Profiles and Antiobesity Effect of a Mixture ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  12. Nutrients · 2021
    Article
  13. Plants (Basel, Switzerland) · 2021
    Article
  14. Oxidative medicine and cellular longevity · 2021
    Review
  15. Anti-Obesity Effects ofNutrients · 2020
    Article
  16. Article
  17. Lactate-FortifiedNutrients · 2020
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yea-Jin ParkDepartment of Pharmacology, College of Korean Medicine, Sangji University, 83, Sangjidae-gil, Wonju-si, Gangwon-do, 26339, Republic of Korea.
Gui-Sun LeeFubonic Cor. 200 Gieopdosi-ro, Jijeong-myeon, Wonju, Gangwon-do, Republic of Korea.
Se-Yun CheonDepartment of Pharmacology, College of Korean Medicine, Sangji University, 83, Sangjidae-gil, Wonju-si, Gangwon-do, 26339, Republic of Korea.
Yun-Yeop ChaDepartment of Rehabilitative Medicine of Korean Medicine and Neuropsychiatry, College of Korean Medicine, Sangji University, Wonju, Gangwon-do, 26339, Republic of Korea.
Hyo-Jin AnDepartment of Pharmacology, College of Korean Medicine, Sangji University, 83, Sangjidae-gil, Wonju-si, Gangwon-do, 26339, Republic of Korea. hjan@sj.ac.kr.
Sangji University · KR

Funding

National Research Foundation of Korea NRF-2017R1D1A1B03034167
6 · The paper itself

Abstract

backgroundRecently, it has been noted that natural herbal medications may be effective in treating obesity. Tongbi-san (TBS) is a traditional medicine usually used for dysuria (i.e., painful urination), containing three herbs, Cyperus rotundus L., Citrus unshiu Markovich, and Poria cocos. In this study, we aimed to examine whether TBS can inhibit high-fat diet (HFD)-induced adipogenesis in the liver and epididymal adipose tissue of obese mice.

methodsMale C57BL/6 N mice were fed a normal diet, an HFD, an HFD plus orlistat 10 or 20 mg/kg, or an HFD plus TBS 50 or 100 mg/kg for 11 weeks. Body weight was checked weekly and histological tissue examinations were investigated. An expression of genes involved in adipogenesis was also assessed.

resultsOral administration of TBS significantly reduced body weight and decreased epididymal and visceral white adipose tissue (WAT) weight. In addition, we found that TBS enhanced the expression of the adenosine monophosphate-activated protein kinase (AMPK) and inhibited the expression of transcription factors, such as CCAAT/enhancer-binding proteins (C/EBPs), sterol regulatory element-binding protein 1 (SREBP1), and peroxisome proliferator-activated receptor γ (PPARγ) in the liver and epididymal WAT as measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR).

conclusionThese findings demonstrate that the anti-obesity effects of TBS may be linked to the activation of AMPK.

Indexed as

Diet, High-FatAdipogenesisAMP-Activated Protein KinasesAnimalsAnti-Obesity AgentsBody WeightDisease Models, AnimalMaleMiceMice, Inbred C57BLMice, ObeseObesityPlant ExtractsAMP-Activated Protein KinasesAnti-Obesity AgentsPlant ExtractsAdipogenesisAMPKHigh-fat dietObesityTongbi-san

Identifiers

PMID30606178
PMCPMC6319014
OpenAlexW2917803216

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.